Carter Gould Score: 40
Analyst at
Cantor Fitzgerald,
Barclays
Avg Return (Buy)
How much profit would you make?
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
+12.2%
1 Year Cap
Win Rate
How often is the direction correct?
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
74%
29 W / 10 L
Target Met
How often was the target reached?
Hits vs. Total.
Hits vs. Total.
74%
17 W / 6 L
Precision Hit
How often precise (±3%)?
Hits vs. Total.
Hits vs. Total.
13%
3 W / 20 L
Bullseye Hit
How often perfect (±1%)?
Hits vs. Total.
Hits vs. Total.
0%
0 W / 23 L
High Conviction
The "Brave" Trades (>20% Upside)
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
70%
7 W / 3 L
Long Wins
Success rate for BUY ratings
How often is the analyst right when saying "Buy"?
(Price went UP).
How often is the analyst right when saying "Buy"?
(Price went UP).
70%
23 W / 10 L
Short Wins
Success rate for SELL ratings
How often is the analyst right when saying "Sell"?
(Price went DOWN).
How often is the analyst right when saying "Sell"?
(Price went DOWN).
100%
6 W / 0 L
Coverage & Price Targets
| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| May 01, 2026 |
Lilly(Eli) & Co
LLY
|
BUY |
$1,230.00
Est. +27%
|
$970.68 | $1,238.00 |
Bullseye Hit (±1%)
|
$1,210.50
+24.7%
|
| Feb 02, 2026 |
Regeneron Pharmaceuticals, Inc.
REGN
|
BUY |
$800.00
Est. +6%
|
$757.59 | $815.00 |
Precision Hit (±3%)
|
$654.27
-13.6%
|
| Nov 04, 2025 |
Vertex Pharmaceuticals, Inc.
VRTX
|
BUY |
$485.00
Est. +14%
|
$427.30 | $529.08 |
Target Met
|
$528.04
+23.6%
|
| Oct 29, 2025 |
Regeneron Pharmaceuticals, Inc.
REGN
|
BUY |
$740.00
Est. +13%
|
$657.00 | $821.11 |
Target Met
|
$654.27
-0.4%
|
| Oct 09, 2025 |
Gilead Sciences, Inc.
GILD
|
BUY |
$135.00
Est. +14%
|
$118.25 | $157.27 |
Target Met
|
$131.27
+11.0%
|
| Sep 15, 2025 |
Abbvie Inc
ABBV
|
BUY |
$245.00
Est. +12%
|
$218.34 | $261.64 |
Target Met
|
$261.07
+19.6%
|
| Aug 13, 2025 |
Lilly(Eli) & Co
LLY
|
BUY |
$825.00
Est. +25%
|
$660.26 | $1,238.00 |
Target Met
|
$1,210.50
+83.3%
|
| Apr 23, 2025 |
Salesforce Inc
CRM
|
SELL |
$210.00
Est. +16%
|
$250.48 | $163.52 (Low) |
Target Met
|
$166.11
+33.7%
|
| Apr 22, 2025 |
Pfizer Inc.
PFE
|
BUY |
$24.00
Est. +7%
|
$22.53 | $28.75 |
Target Met
|
$24.32
+7.9%
|
| Apr 22, 2025 |
Gilead Sciences, Inc.
GILD
|
BUY |
$125.00
Est. +18%
|
$105.51 | $157.27 |
Target Met
|
$131.27
+24.4%
|
| Apr 22, 2025 |
Regeneron Pharmaceuticals, Inc.
REGN
|
BUY |
$695.00
Est. +19%
|
$585.49 | $821.11 |
Target Met
|
$654.27
+11.7%
|
| Oct 07, 2024 |
AMGEN Inc.
AMGN
|
SELL |
$315.00
Est. +1%
|
$319.66 | $257.05 (Low) |
Target Met
|
$374.15
-17.0%
|
| Oct 07, 2024 |
Merck & Co Inc
MRK
|
BUY |
$140.00
Est. +28%
|
$109.77 | $111.58 |
Miss
|
$129.52
+18.0%
|
| Oct 01, 2024 |
Travere Therapeutics Inc
TVTX
|
BUY |
$18.00
Est. +29%
|
$13.99 | $28.69 |
Target Met
|
$56.92
+306.9%
|
| Sep 25, 2024 |
Pfizer Inc.
PFE
|
BUY |
$32.00
Est. +11%
|
$28.93 | $30.43 |
Miss
|
$24.32
-15.9%
|
| Sep 09, 2024 |
Neurocrine Biosciences, Inc.
NBIX
|
BUY |
$160.00
Est. +33%
|
$120.17 | $154.61 |
Miss
|
$174.26
+45.0%
|
| Jul 29, 2024 |
Bristol-Myers Squibb Co.
BMY
|
SELL |
$41.00
Est. +19%
|
$50.45 | $44.00 (Low) |
Miss
|
$58.13
-15.2%
|
| Jul 10, 2024 |
Pfizer Inc.
PFE
|
BUY |
$30.00
Est. +8%
|
$27.72 | $31.54 |
Target Met
|
$24.32
-12.3%
|
| Jun 13, 2024 |
Barinthus Biotherapeutics Plc. - ADR
BRNS
|
BUY |
$3.00
Est. +58%
|
$1.90 | $1.58 |
Miss
|
$0.62
-67.4%
|
| May 23, 2024 |
Cytokinetics Inc
CYTK
|
BUY |
$95.00
Est. +60%
|
$59.23 | $61.37 |
Miss
|
$86.49
+46.0%
|
| May 03, 2024 |
AMGEN Inc.
AMGN
|
BUY |
$300.00
Est. +8%
|
$278.39 | $346.85 |
Target Met
|
$374.15
+34.4%
|
| Apr 03, 2024 |
Biogen Inc
BIIB
|
BUY |
$215.00
Est. +4%
|
$206.38 | $237.98 |
Target Met
|
$216.12
+4.7%
|
| Mar 27, 2024 |
Abbvie Inc
ABBV
|
BUY |
$195.00
Est. +8%
|
$179.79 | $218.66 |
Target Met
|
$261.07
+45.2%
|
| Oct 31, 2022 |
Gilead Sciences, Inc.
GILD
|
SELL |
$76.00
Est. +4%
|
$79.27 | - | - |
$131.27
-65.6%
|
| Oct 31, 2022 |
AMGEN Inc.
AMGN
|
SELL |
$234.00
Est. +15%
|
$273.81 | - | - |
$374.15
-36.6%
|
| Apr 16, 2022 |
Merck & Co Inc
MRK
|
BUY |
$97.00
Est. +12%
|
$86.91 | - | - |
$129.52
+49.0%
|
| Apr 16, 2022 |
Biogen Inc
BIIB
|
BUY |
$219.00
Est. +3%
|
$212.55 | - | - |
$216.12
+1.7%
|
| Apr 16, 2022 |
Abbvie Inc
ABBV
|
BUY |
$174.00
Est. +7%
|
$162.31 | - | - |
$261.07
+60.8%
|
| Apr 16, 2022 |
Regeneron Pharmaceuticals, Inc.
REGN
|
BUY |
$745.00
Est. +2%
|
$733.02 | - | - |
$654.27
-10.7%
|
| Apr 16, 2022 |
AMGEN Inc.
AMGN
|
SELL |
$236.00
Est. +7%
|
$254.02 | - | - |
$374.15
-47.3%
|
| Feb 08, 2022 |
Pfizer Inc.
PFE
|
BUY |
$54.00
Est. +4%
|
$51.70 | - | - |
$24.32
-53.0%
|
| Feb 07, 2022 |
Regeneron Pharmaceuticals, Inc.
REGN
|
BUY |
$700.00
Est. +12%
|
$622.36 | - | - |
$654.27
+5.1%
|
| Feb 04, 2022 |
Biogen Inc
BIIB
|
BUY |
$235.00
Est. +6%
|
$221.53 | - | - |
$216.12
-2.4%
|
| Feb 03, 2022 |
Abbvie Inc
ABBV
|
BUY |
$150.00
Est. +7%
|
$140.73 | - | - |
$261.07
+85.5%
|
| Jan 20, 2022 |
Neurocrine Biosciences, Inc.
NBIX
|
BUY |
$100.00
Est. +37%
|
$72.80 | - | - |
$174.26
+139.4%
|
| Dec 20, 2021 |
Lilly(Eli) & Co
LLY
|
BUY |
$325.00
Est. +24%
|
$262.38 | - | - |
$1,210.50
+361.4%
|
| Dec 20, 2021 |
Cytokinetics Inc
CYTK
|
BUY |
$52.00
Est. +32%
|
$39.50 | - | - |
$86.49
+119.0%
|
| Nov 01, 2021 |
Merck & Co Inc
MRK
|
BUY |
$94.00
Est. +9%
|
$86.25 | - | - |
$129.52
+50.2%
|
| Oct 28, 2021 |
Bristol-Myers Squibb Co.
BMY
|
BUY |
$66.00
Est. +17%
|
$56.22 | - | - |
$58.13
+3.4%
|
Lilly(Eli) & Co
LLY
May 01, 2026
Signal & Target
BUY
$1,230.00
Start Price
$970.68
Best Price (1Y)
$1,238.00
Current Price
$1,210.50
Return
+24.7%
Regeneron Pharmaceuticals, Inc.
REGN
Feb 02, 2026
Signal & Target
BUY
$800.00
Start Price
$757.59
Best Price (1Y)
$815.00
Current Price
$654.27
Return
-13.6%
Vertex Pharmaceuticals, Inc.
VRTX
Nov 04, 2025
Signal & Target
BUY
$485.00
Start Price
$427.30
Best Price (1Y)
$529.08
Current Price
$528.04
Return
+23.6%
Regeneron Pharmaceuticals, Inc.
REGN
Oct 29, 2025
Signal & Target
BUY
$740.00
Start Price
$657.00
Best Price (1Y)
$821.11
Current Price
$654.27
Return
-0.4%
Gilead Sciences, Inc.
GILD
Oct 09, 2025
Signal & Target
BUY
$135.00
Start Price
$118.25
Best Price (1Y)
$157.27
Current Price
$131.27
Return
+11.0%
Abbvie Inc
ABBV
Sep 15, 2025
Signal & Target
BUY
$245.00
Start Price
$218.34
Best Price (1Y)
$261.64
Current Price
$261.07
Return
+19.6%
Lilly(Eli) & Co
LLY
Aug 13, 2025
Signal & Target
BUY
$825.00
Start Price
$660.26
Best Price (1Y)
$1,238.00
Current Price
$1,210.50
Return
+83.3%
Salesforce Inc
CRM
Apr 23, 2025
Signal & Target
SELL
$210.00
Start Price
$250.48
Best Price (1Y)
$163.52
Current Price
$166.11
Return
+33.7%
Pfizer Inc.
PFE
Apr 22, 2025
Signal & Target
BUY
$24.00
Start Price
$22.53
Best Price (1Y)
$28.75
Current Price
$24.32
Return
+7.9%
Gilead Sciences, Inc.
GILD
Apr 22, 2025
Signal & Target
BUY
$125.00
Start Price
$105.51
Best Price (1Y)
$157.27
Current Price
$131.27
Return
+24.4%
Regeneron Pharmaceuticals, Inc.
REGN
Apr 22, 2025
Signal & Target
BUY
$695.00
Start Price
$585.49
Best Price (1Y)
$821.11
Current Price
$654.27
Return
+11.7%
AMGEN Inc.
AMGN
Oct 07, 2024
Signal & Target
SELL
$315.00
Start Price
$319.66
Best Price (1Y)
$257.05
Current Price
$374.15
Return
-17.0%
Merck & Co Inc
MRK
Oct 07, 2024
Signal & Target
BUY
$140.00
Start Price
$109.77
Best Price (1Y)
$111.58
Current Price
$129.52
Return
+18.0%
Travere Therapeutics Inc
TVTX
Oct 01, 2024
Signal & Target
BUY
$18.00
Start Price
$13.99
Best Price (1Y)
$28.69
Current Price
$56.92
Return
+306.9%
Pfizer Inc.
PFE
Sep 25, 2024
Signal & Target
BUY
$32.00
Start Price
$28.93
Best Price (1Y)
$30.43
Current Price
$24.32
Return
-15.9%
Neurocrine Biosciences, Inc.
NBIX
Sep 09, 2024
Signal & Target
BUY
$160.00
Start Price
$120.17
Best Price (1Y)
$154.61
Current Price
$174.26
Return
+45.0%
Bristol-Myers Squibb Co.
BMY
Jul 29, 2024
Signal & Target
SELL
$41.00
Start Price
$50.45
Best Price (1Y)
$44.00
Current Price
$58.13
Return
-15.2%
Pfizer Inc.
PFE
Jul 10, 2024
Signal & Target
BUY
$30.00
Start Price
$27.72
Best Price (1Y)
$31.54
Current Price
$24.32
Return
-12.3%
Barinthus Biotherapeutics Plc. - ADR
BRNS
Jun 13, 2024
Signal & Target
BUY
$3.00
Start Price
$1.90
Best Price (1Y)
$1.58
Current Price
$0.62
Return
-67.4%
Cytokinetics Inc
CYTK
May 23, 2024
Signal & Target
BUY
$95.00
Start Price
$59.23
Best Price (1Y)
$61.37
Current Price
$86.49
Return
+46.0%
AMGEN Inc.
AMGN
May 03, 2024
Signal & Target
BUY
$300.00
Start Price
$278.39
Best Price (1Y)
$346.85
Current Price
$374.15
Return
+34.4%
Biogen Inc
BIIB
Apr 03, 2024
Signal & Target
BUY
$215.00
Start Price
$206.38
Best Price (1Y)
$237.98
Current Price
$216.12
Return
+4.7%
Abbvie Inc
ABBV
Mar 27, 2024
Signal & Target
BUY
$195.00
Start Price
$179.79
Best Price (1Y)
$218.66
Current Price
$261.07
Return
+45.2%
Gilead Sciences, Inc.
GILD
Oct 31, 2022
Signal & Target
SELL
$76.00
Start Price
$79.27
Best Price (1Y)
-
Current Price
$131.27
Return
-65.6%
AMGEN Inc.
AMGN
Oct 31, 2022
Signal & Target
SELL
$234.00
Start Price
$273.81
Best Price (1Y)
-
Current Price
$374.15
Return
-36.6%
Merck & Co Inc
MRK
Apr 16, 2022
Signal & Target
BUY
$97.00
Start Price
$86.91
Best Price (1Y)
-
Current Price
$129.52
Return
+49.0%
Biogen Inc
BIIB
Apr 16, 2022
Signal & Target
BUY
$219.00
Start Price
$212.55
Best Price (1Y)
-
Current Price
$216.12
Return
+1.7%
Abbvie Inc
ABBV
Apr 16, 2022
Signal & Target
BUY
$174.00
Start Price
$162.31
Best Price (1Y)
-
Current Price
$261.07
Return
+60.8%
Regeneron Pharmaceuticals, Inc.
REGN
Apr 16, 2022
Signal & Target
BUY
$745.00
Start Price
$733.02
Best Price (1Y)
-
Current Price
$654.27
Return
-10.7%
AMGEN Inc.
AMGN
Apr 16, 2022
Signal & Target
SELL
$236.00
Start Price
$254.02
Best Price (1Y)
-
Current Price
$374.15
Return
-47.3%
Pfizer Inc.
PFE
Feb 08, 2022
Signal & Target
BUY
$54.00
Start Price
$51.70
Best Price (1Y)
-
Current Price
$24.32
Return
-53.0%
Regeneron Pharmaceuticals, Inc.
REGN
Feb 07, 2022
Signal & Target
BUY
$700.00
Start Price
$622.36
Best Price (1Y)
-
Current Price
$654.27
Return
+5.1%
Biogen Inc
BIIB
Feb 04, 2022
Signal & Target
BUY
$235.00
Start Price
$221.53
Best Price (1Y)
-
Current Price
$216.12
Return
-2.4%
Abbvie Inc
ABBV
Feb 03, 2022
Signal & Target
BUY
$150.00
Start Price
$140.73
Best Price (1Y)
-
Current Price
$261.07
Return
+85.5%
Neurocrine Biosciences, Inc.
NBIX
Jan 20, 2022
Signal & Target
BUY
$100.00
Start Price
$72.80
Best Price (1Y)
-
Current Price
$174.26
Return
+139.4%
Lilly(Eli) & Co
LLY
Dec 20, 2021
Signal & Target
BUY
$325.00
Start Price
$262.38
Best Price (1Y)
-
Current Price
$1,210.50
Return
+361.4%
Cytokinetics Inc
CYTK
Dec 20, 2021
Signal & Target
BUY
$52.00
Start Price
$39.50
Best Price (1Y)
-
Current Price
$86.49
Return
+119.0%
Merck & Co Inc
MRK
Nov 01, 2021
Signal & Target
BUY
$94.00
Start Price
$86.25
Best Price (1Y)
-
Current Price
$129.52
Return
+50.2%
Bristol-Myers Squibb Co.
BMY
Oct 28, 2021
Signal & Target
BUY
$66.00
Start Price
$56.22
Best Price (1Y)
-
Current Price
$58.13
Return
+3.4%